Advanced search
1 file | 5.78 MB Add to list

Modelling drug transport during intraperitoneal chemotherapy

Margo Steuperaert (UGent) , Charlotte Debbaut (UGent) , Patrick Segers (UGent) and Wim Ceelen (UGent)
(2017) PLEURA AND PERITONEUM. 2(2). p.73-83
Author
Organization
Abstract
Despite a strong rationale for intraperitoneal (IP) chemotherapy, the actual use of the procedure is limited by the poor penetration depth of the drug into the tissue. Drug penetration into solid tumours is a complex mass transport process that involves multiple parameters not only related to the used cytotoxic agent but also to the tumour tissue properties and even the therapeutic setup. Mathematical modelling can provide unique insights into the different transport barriers that occur during IP chemotherapy as well as offer the possibility to test different protocols or drugs without the need for in vivo experiments. In this work, a distinction is made between three different types of model: the lumped parameter model, the distributed model and the cell-based model. For each model, we discuss which steps of the transport process are included and where assumptions are made. Finally, we focus on the advantages and main limitations of each category and discuss some future perspectives for the modelling of IP chemotherapy.
Keywords
drug transport, intraperitoneal chemotherapy, mathematical modelling, theoretical modelling, INTERSTITIAL FLUID PRESSURE, CANCER CELL-LINES, OVARIAN-CANCER, PERITONEAL CARCINOMATOSIS, MATHEMATICAL-MODEL, SOLID TUMORS, IN-VITRO, ANTITUMOR-ACTIVITY, BRAIN-TUMOR, CISPLATIN

Downloads

  • (...).pdf
    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 5.78 MB

Citation

Please use this url to cite or link to this publication:

MLA
Steuperaert, Margo, Charlotte Debbaut, Patrick Segers, et al. “Modelling Drug Transport During Intraperitoneal Chemotherapy.” PLEURA AND PERITONEUM 2.2 (2017): 73–83. Print.
APA
Steuperaert, M., Debbaut, C., Segers, P., & Ceelen, W. (2017). Modelling drug transport during intraperitoneal chemotherapy. PLEURA AND PERITONEUM, 2(2), 73–83.
Chicago author-date
Steuperaert, Margo, Charlotte Debbaut, Patrick Segers, and Wim Ceelen. 2017. “Modelling Drug Transport During Intraperitoneal Chemotherapy.” Pleura and Peritoneum 2 (2): 73–83.
Chicago author-date (all authors)
Steuperaert, Margo, Charlotte Debbaut, Patrick Segers, and Wim Ceelen. 2017. “Modelling Drug Transport During Intraperitoneal Chemotherapy.” Pleura and Peritoneum 2 (2): 73–83.
Vancouver
1.
Steuperaert M, Debbaut C, Segers P, Ceelen W. Modelling drug transport during intraperitoneal chemotherapy. PLEURA AND PERITONEUM. 2017;2(2):73–83.
IEEE
[1]
M. Steuperaert, C. Debbaut, P. Segers, and W. Ceelen, “Modelling drug transport during intraperitoneal chemotherapy,” PLEURA AND PERITONEUM, vol. 2, no. 2, pp. 73–83, 2017.
@article{8525183,
  abstract     = {Despite a strong rationale for intraperitoneal (IP) chemotherapy, the actual use of the procedure is limited by the poor penetration depth of the drug into the tissue. Drug penetration into solid tumours is a complex mass transport process that involves multiple parameters not only related to the used cytotoxic agent but also to the tumour tissue properties and even the therapeutic setup. Mathematical modelling can provide unique insights into the different transport barriers that occur during IP chemotherapy as well as offer the possibility to test different protocols or drugs without the need for in vivo experiments. In this work, a distinction is made between three different types of model: the lumped parameter model, the distributed model and the cell-based model. For each model, we discuss which steps of the transport process are included and where assumptions are made. Finally, we focus on the advantages and main limitations of each category and discuss some future perspectives for the modelling of IP chemotherapy.},
  author       = {Steuperaert, Margo and Debbaut, Charlotte and Segers, Patrick and Ceelen, Wim},
  issn         = {2364-7671},
  journal      = {PLEURA AND PERITONEUM},
  keywords     = {drug transport,intraperitoneal chemotherapy,mathematical modelling,theoretical modelling,INTERSTITIAL FLUID PRESSURE,CANCER CELL-LINES,OVARIAN-CANCER,PERITONEAL CARCINOMATOSIS,MATHEMATICAL-MODEL,SOLID TUMORS,IN-VITRO,ANTITUMOR-ACTIVITY,BRAIN-TUMOR,CISPLATIN},
  language     = {eng},
  number       = {2},
  pages        = {73--83},
  title        = {Modelling drug transport during intraperitoneal chemotherapy},
  url          = {http://dx.doi.org/10.1515/pp-2017-0004},
  volume       = {2},
  year         = {2017},
}

Altmetric
View in Altmetric